September 2007

Cover Story
Studies by Cigna and Humana challenge some long-held assumptions about high-deductible plans

John Carroll

Gauging and rewarding good work in health care is a noble goal with potentially negative consequences

Martin Sipkoff

Even if the the goal is unattainable in this country, working toward it might produce interesting experiments in cost efficiency

Frank Diamond

The pros and cons of each weigh heavily, but ultimately, a melding may benefit patients and primary care physicians

Jaan Sidorov, MD, MHSA

Peer-Reviewed
Payers' drug costs for human growth hormone are related to product waste that is related to the container in which the product is supplied

Gary R. Bazalo, MS ; Ashish V. Joshi, PhD ; John Germak, MD

Legislation & Regulation
That seems to be the upshot of the debate over funding children's insurance and Medicare Advantage

John Carroll

Medication Management
Thanks to recent Supreme Court rulings, manufacturers of generic drugs are in a good position to continue expansion of their market share

Martin Sipkoff

Compensation Monitor
Tomorrow’s Medicine
Otosclerosis has been traditionally managed with hearing aids and surgery, but a recent discovery may result in development of a biochemical treatment

Thomas Morrow, MD

Employer Update
Plans seem curiously unconcerned about technology that helps workers compare premiums, other features

Lola Butcher